Thank you for signing up!

You should receive a confirmation
email shortly.

Home

You are now leaving

www.MoreAboutSBS.com

The website you are linking to is neither owned nor controlled by Ironwood.

Ironwood is not responsible for the content or services on the site.

Understanding sbs

SBS is a complex, chronic condition, and affected patients have unique needs2,3

Learn more about how
SBS affects patients

Life with sbs

While SBS management has improved, many patients face significant challenges that impact their daily lives4

Discover how SBS creates
challenges for patients

our commitment

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

REFERENCES —

1. Jeppesen PB. Spectrum of short bowel syndrome in adults: intestinal insufficiency to intestinal failure. JPEN J Parenter Enteral Nutr. 2014;38(suppl 1):8S-13S. doi:10.1177/0148607114520994

2. Belcher E, Mercer D, Raphael BP, Salinas GD, Stacy S, Tappenden KA. Management of short-bowel syndrome: a survey of unmet educational needs among healthcare providers. JPEN J Parenter Enteral Nutr. 2022;46(8):1839-1846. doi:10.1002/jpen.2388

3. Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015;34(2):171-180. doi:10.1016/j.clnu.2014.08.017

4. Parrish CR, DiBaise JK. Managing the adult patient with short bowel syndrome. Gastroenterol Hepatol (NY). 2017;13(10):600-608.

Privacy Policy|Terms and Conditions|Contact Us

Ironwood® and its three-leaf design are registered trademarks of Ironwood Pharmaceuticals, Inc. © 2024 Ironwood Pharmaceuticals, Inc. All rights reserved.

This site is intended for licensed US healthcare professionals only.